1 Department of Ophthalmology, Kresge Eye Institute, Wayne State University, Detroit, Michigan.
2 Department of Anatomy/Cell Biology, Kresge Eye Institute, Wayne State University, Detroit, Michigan.
Antioxid Redox Signal. 2019 May 1;30(13):1621-1634. doi: 10.1089/ars.2018.7542. Epub 2018 Oct 3.
Diabetes increases oxidative stress in the retina and dysfunctions their mitochondria, accelerating capillary cell apoptosis. A 66 kDa adaptor protein, p66Shc, is considered as a sensor of oxidative stress-induced apoptosis. In the pathogenesis of diabetic retinopathy, a progressive disease, reactive oxygen species (ROS) production by activation of a small molecular weight G-protein (Ras-related C3 botulinum toxin substrate 1 [Rac1])-Nox2 signaling precedes mitochondrial damage. Rac1 activation is facilitated by guanine exchange factors (GEFs), and p66Shc increases Rac1-specific GEF activity of Son of Sevenless 1 (Sos1). p66Shc also possesses oxidoreductase activity and can directly stimulate mitochondrial ROS generation. Our aim was to investigate the role of p66Shc in the development of diabetic retinopathy and mechanism of its transcription.
High glucose increased p66Shc expression in human retinal endothelial cells, and elevated acetylated histone 3 lysine 9 (H3K9) levels and transcriptional factor p53 binding at its promoter. Glucose also augmented interactions between Rac1 and Sos1 and activated Rac1-Nox2. Phosphorylation of p66Shc was increased, allowing it to interact with peptidyl prolyl isomerase to facilitate its localization inside the mitochondria, culminating in mitochondrial damage. P66shc-small interfering RNA (siRNA) inhibited glucose-induced Rac1 activation and mitochondrial damage. Similar results are observed in retinal microvessels from diabetic rats.
This is the first report identifying the role of p66Shc in the development of diabetic retinopathy and implicating increased histone acetylation in its transcriptional regulation.
Thus, p66Shc has dual role in the development of diabetic retinopathy; its regulation in the early stages of the disease should impede Rac1-ROS production and, in the later stages, prevent mitochondrial damage and initiation of a futile cycle of free radicals.
糖尿病会增加视网膜中的氧化应激,并使线粒体功能障碍,加速毛细血管细胞凋亡。一种 66kDa 的衔接蛋白 p66Shc 被认为是氧化应激诱导细胞凋亡的传感器。在糖尿病性视网膜病变这一进行性疾病的发病机制中,小分子 G 蛋白(Ras 相关 C3 肉毒杆菌毒素底物 1 [Rac1])-Nox2 信号的激活会导致活性氧(ROS)的产生,从而导致线粒体损伤。Rac1 的激活受到鸟嘌呤交换因子(GEFs)的促进,而 p66Shc 增加了 Son of Sevenless 1(Sos1)的 Rac1 特异性 GEF 活性。p66Shc 还具有氧化还原酶活性,可直接刺激线粒体 ROS 的产生。我们的目的是研究 p66Shc 在糖尿病性视网膜病变发展中的作用及其转录机制。
高葡萄糖增加了人视网膜内皮细胞中 p66Shc 的表达,并提高了乙酰化组蛋白 3 赖氨酸 9(H3K9)水平和其启动子处转录因子 p53 的结合。葡萄糖还增加了 Rac1 和 Sos1 之间的相互作用,并激活了 Rac1-Nox2。p66Shc 的磷酸化增加,使其能够与肽基脯氨酰顺反异构酶相互作用,促进其在线粒体中的定位,最终导致线粒体损伤。p66Shc 小干扰 RNA(siRNA)抑制了葡萄糖诱导的 Rac1 激活和线粒体损伤。在糖尿病大鼠的视网膜微血管中也观察到了类似的结果。
这是首次报道鉴定 p66Shc 在糖尿病性视网膜病变发展中的作用,并表明组蛋白乙酰化增加参与其转录调控。
因此,p66Shc 在糖尿病性视网膜病变的发展中具有双重作用;在疾病的早期阶段,其调节应能阻止 Rac1-ROS 的产生,而在晚期阶段,则应能防止线粒体损伤和自由基无效循环的启动。